Filing Details

Accession Number:
0000950170-24-101166
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-08-27 18:57:46
Reporting Period:
2024-08-23
Accepted Time:
2024-08-27 18:57:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1783328 Tscan Therapeutics Inc. TCRX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1647647 Barbara Klencke C/O Tscan Therapeutics, Inc.
830 Winter Street
Waltham MA 02451
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Voting Common Stock Acquisiton 2024-08-23 5,000 $5.69 35,000 No 4 P Direct
Voting Common Stock Acquisiton 2024-08-26 5,000 $5.53 40,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Voting Common Stock 25,000 Indirect By Trust
Footnotes
  1. Shares held by the Klencke Huestis Trust, for which the Reporting Person serves as co-trustee along with her spouse. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.